Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. [electronic resource]
Producer: 20040702Description: 981-6 p. digitalISSN:- 0305-7453
- Administration, Inhalation
- Aerosols
- Animals
- Antibiotics, Antitubercular -- administration & dosage
- Antitubercular Agents -- administration & dosage
- Area Under Curve
- Biological Availability
- Chemical Phenomena
- Chemical and Drug Induced Liver Injury -- pathology
- Chemistry, Physical
- Colony Count, Microbial
- Drug Carriers
- Drug Combinations
- Drug Compounding
- Female
- Guinea Pigs
- Half-Life
- Injections, Intravenous
- Isoniazid -- administration & dosage
- Lactic Acid
- Lung -- metabolism
- Male
- Microspheres
- Mycobacterium tuberculosis -- drug effects
- Particle Size
- Polyglycolic Acid
- Polylactic Acid-Polyglycolic Acid Copolymer
- Polymers
- Pyrazinamide -- administration & dosage
- Rifampin -- administration & dosage
- Tuberculosis -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.